Neisvac C Baxter
NeisVac-C® Vaccine
All Rights Reserved ® NeisVac-C is a trademark of Baxter International Inc., used under license by GlaxoSmithKline Inc. Last revised: January 21, 2009
gsk.ca
NeisVac-C Vaccine
Name and address of the sponsor NeisVac-C vaccine is manufactured by: BioScience Division Baxter Healthcare Corporation Beltsville, Maryland, USA. Distributed in Australia by: Baxter Healthcare Pty Ltd ABN 43 000 392 781 1 Baxter Drive Toongabbie NSW 2146, Sydney The last CMI revision: March 2006
www.mydr.com.au
Products & Services Directory
Baxter provides vaccines for meningitis C, tick-borne encephalitis, and ... NEISVAC-C† VACCINE
www.baxter.com
SUMMARY OF PRODUCT CHARACTERISTICS
Booster doses It is recommended that a booster dose should be given after completion of the primary immunisation series in infants. The timing of this dose should be in accordance with 1 NeisVac-C is a trademark of Baxter International Inc.
www.immunisation.ie
Patient Group Direction for the administration of ...
NeisVac-C ® (Baxter Healthcare Ltd) is a suspension for injection in a 0.5mL pre-filled syringe. The vaccine should be well shaken before use in order to obtain a homogenous suspension.
www.nhsgrampian.com
Report of the Committee on Safety of Medicines Expert Working ...
Subsequently immunisation with Meningitis C vaccines became part of the routine infant immunisation programme, being given at ages two, three and four months. 1.2 Licensing of Meningitis C Vaccines Three vaccines were used in the campaign : Meningitec (Wyeth), Menjugate (Chiron) and Neisvac-C (Baxter).
www.mhra.gov.uk
Interim guidelines for immunisation providers
These interim recommendations relate only to the Meningococcal C conjugate vaccines (MenCCV), specifically Meningitec (Wyeth), Menjugate (CSL Vaccines/Chiron) and NeisVac-C (Baxter Healthcare).
www.nevdgp.org.au
Patient Group Direction for administration of X medication
NeisVac-C® (Baxter) Summary of Product Characteristics last updated: 21/01/2009 http://www.gsk.ca/english/docs-pdf/NeisVacC_PM_20090121_EN. pdf
www.leeds.nhs.uk
Carbohydrate Based Vaccines
Neisseriameningitidis Capsular Neisseriameningitidis Capsular Polysaccharide-Conjugate Vaccine Polysaccharide-Conjugate Vaccine Meningitec® : Wyeth Meningitec®: Wyeth Menjugate® : Chiron Menjugate®: Chiron NeisVac NeisVac-C®-C®: Baxter Protein-CPS conjugate vaccines are currently Protein-CPS ...
www.ccrc.uga.edu
Meningococcal disease - Fact sheet - NCIRS - PDF
Meningococcal C conjugate vaccines 5 Meningitec - Wyeth Australia Pty Ltd: meningococcal serogroup C-CRM 197 conjugate vaccine Menjugate syringe - CSL Biotherapies/Novartis Vaccines and Diagnostics: meningococcal serogroup C-CRM 197 conjugate vaccine NeisVac-C - Baxter Healthcare: meningococcal serogroup C ...
www.ncirs.edu.au
Other sites you could try:
Find videos related to Neisvac C Baxter